GlobeNews Wire

Roadzen Subsidiary drivebuddyAI Granted Patent for Real-Time Lane Detection System; Demonstrates Technology at InCabin Detroit 2026

WILMINGTON, Del., June 15, 2026 (GLOBE NEWSWIRE) -- Roadzen Inc. (Nasdaq: RDZN), a global leader in AI at the convergence…

6 days ago

As Retail Traders Vibe-Code Their Own AI Day Trading Bots, SaintQuant Offers a More Reliable Path to Automated Trading

While a new wave of DIY trading bots floods the market, SaintQuant delivers professionally built AI quantitative strategies — no…

6 days ago

Intravacc and SynphaBase Announce Strategic Partnership to Advance Conjugate Vaccine Development

The companies will combine their complementary expertise in synthetic oligosaccharides, conjugation process development and GMP vaccine manufacturing to support partners…

7 days ago

2026 EHA | Over 40 Orelabrutinib Studies Presented, Including First Clinical Data from Europe and US TN CLL/SLL Patients

BEIJING, June 15, 2026 (GLOBE NEWSWIRE) -- InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on the…

7 days ago

Ascentage Pharma Presents Multiple Clinical Updates at EHA2026 Congress

Poster presentations from ongoing clinical trials of two core assets, olverembatinib and lisaftoclax, highlight global innovation capabilities in hematologic malignancies…

7 days ago

Modat adds Passive DNS to its Platform Magnify, Connecting Every Signal in a Single Investigation Graph

THE HAGUE, the Netherlands, June 14, 2026 (GLOBE NEWSWIRE) -- Modat today launched native Passive DNS intelligence in Magnify, its…

1 week ago

XM Announces Enhanced Trading Conditions and Opportunities for Global Traders – Featuring Partner Code 274PQ

TORONTO, June 14, 2026 (GLOBE NEWSWIRE) -- As participation in online financial markets continues to expand worldwide, trading platforms are…

1 week ago

FemiCore [Exclusive Report 2026] Femi Core Warning Why Thousands of Women Are Suddenly Talking About This Bladder Health Supplement

New York City, NY, June 13, 2026 (GLOBE NEWSWIRE) -- In a year filled with trending wellness products, few supplements…

1 week ago

Legend Biotech Establishes Clinical Proof-of-Concept for LB2501, a Potential First-in-Class In Vivo CD19/CD20 Dual-Targeting CAR-T, in Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma

 Achieved 100% ORR and 83.3% CR rate at dose level 2 following a single infusion in patients with relapsed/refractory B-NHL…

1 week ago

KFSH Highlights Human-Centered AI as a Path to Better Care at HLTH Europe 2026

RIYADH, Saudi Arabia, June 14, 2026 (GLOBE NEWSWIRE) -- At HLTH Europe 2026 in Amsterdam, taking place from June 15…

1 week ago